DrugPatentWatch Database Preview
Loxo Oncology Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for LOXO ONCOLOGY INC, and what generic alternatives to LOXO ONCOLOGY INC drugs are available?
LOXO ONCOLOGY INC has one approved drug.
There are four US patents protecting LOXO ONCOLOGY INC drugs.
There are thirty-four patent family members on LOXO ONCOLOGY INC drugs in twenty-four countries.
Summary for Loxo Oncology Inc
| International Patents: | 34 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Loxo Oncology Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Loxo Oncology Inc | RETEVMO | selpercatinib | CAPSULE;ORAL | 213246-001 | May 8, 2020 | RX | Yes | No | Start Trial | Start Trial | |||||
| Loxo Oncology Inc | RETEVMO | selpercatinib | CAPSULE;ORAL | 213246-002 | May 8, 2020 | RX | Yes | Yes | 10,137,124 | Start Trial | Start Trial | ||||
| Loxo Oncology Inc | RETEVMO | selpercatinib | CAPSULE;ORAL | 213246-002 | May 8, 2020 | RX | Yes | Yes | 10,584,124 | Start Trial | Y | Start Trial | |||
| Loxo Oncology Inc | RETEVMO | selpercatinib | CAPSULE;ORAL | 213246-002 | May 8, 2020 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Loxo Oncology Inc | RETEVMO | selpercatinib | CAPSULE;ORAL | 213246-001 | May 8, 2020 | RX | Yes | No | Start Trial | Start Trial | |||||
| Loxo Oncology Inc | RETEVMO | selpercatinib | CAPSULE;ORAL | 213246-001 | May 8, 2020 | RX | Yes | No | 10,112,942 | Start Trial | Y | Y | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Loxo Oncology Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Denmark | 3523301 | Start Trial |
| Israel | 265916 | Start Trial |
| Australia | 2017342022 | Start Trial |
| South Korea | 20190076976 | Start Trial |
| Israel | 273730 | Start Trial |
| European Patent Office | 3523301 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
